80 FR 46334 - Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 149 (August 4, 2015)

Page Range		46334-46334
FR Document		2015-19168

Cody Laboratories, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 80 Issue 149 (Tuesday, August 4, 2015)

[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Page 46334]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19168]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Cody 
Laboratories, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Cody Laboratories, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015, 80 FR 22560, Cody 
Laboratories, Inc., Steve Hartman-Vice President of Compliance, 601 
Yellowstone Avenue, Cody, Wyoming 82414 applied to be registered as a 
manufacturer of certain basic classes of controlled substances. No 
comments or objections were submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Cody Laboratories, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)    II
 (8333).
Phenylacetone (8501).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Ecgonine (9180)............................  II
Hydrocodone (9193).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Oxymorphone (9652).........................  II
Alfentanil (9737)..........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers.

    Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19168 Filed 8-3-15; 8:45 am]
BILLING CODE P

46334 Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices

and analytical purposes. Placement of Administrator’’) pursuant to section 7 of the public interest and with United
these drug codes onto the company’s 28 CFR part 0, appendix to subpart R. States obligations under international
registration does not translate into In accordance with 21 CFR treaties, conventions, or protocols in
automatic approval of subsequent 1301.33(a), this is notice that on July 28, effect on May 1, 1971. The DEA
permit applications to import controlled 2014, Cedarburg Pharmaceuticals, Inc., investigated the company’s maintenance
substances. Approval of permit 870 Badger Circle, Grafton, Wisconsin of effective controls against diversion by
applications will occur only when the 53024 applied to be registered as a bulk inspecting and testing the company’s
registrant’s business activity is manufacturer of the following basic physical security systems, verifying the
consistent with what is authorized classes of controlled substances: company’s compliance with state and
under to 21 U.S.C. 952(a)(2). local laws, and reviewing the company’s
Authorization will not extend to the Controlled substance Schedule background and history.
import of FDA approved or non- Therefore, pursuant to 21 U.S.C.
Marihuana (7360) ......................... I
approved finished dosage forms for Tetrahydrocannabinols (7370) ..... I 823(a), and in accordance with 21 CFR
commercial sale. 1301.33, the above-named company is
Dated: July 29, 2015. The company plans to manufacture granted registration as a bulk
Joseph T. Rannazzisi, the above-listed controlled substances manufacturer of the basic classes of
in bulk for distribution to its customers. controlled substances listed:
Deputy Assistant Administrator.
[FR Doc. 2015–19158 Filed 8–3–15; 8:45 am] In reference to drug code 7360
marihuana, the company plans to bulk Controlled substance Schedule
BILLING CODE 4410–09–P
manufacture cannabidiol as a synthetic Dihydromorphine (9145) ............... I
intermediate. This controlled substance Amphetamine (1100) .................... II
DEPARTMENT OF JUSTICE will be further synthesized to bulk Methamphetamine (1105) ............ II
manufacture a synthetic Amobarbital (2125) ....................... II
Drug Enforcement Administration tetrahydrocannabinol 7370. No other Pentobarbital (2270) ..................... II
activity for this drug code is authorized Secobarbital (2315) ...................... II
[Docket No. DEA–392] for this registration. 4-Anilino-N-phenethyl-4-piperidine II
(ANPP) (8333).
Dated: July 29, 2015. Phenylacetone (8501) .................. II
Bulk Manufacturer of Controlled
Joseph T. Rannazzisi, Cocaine (9041) ............................. II
Substances Application: Cedarburg
Deputy Assistant Administrator. Codeine (9050) ............................. II
Pharmaceuticals, Inc. Dihydrocodeine (9120) ................. II
[FR Doc. 2015–19165 Filed 8–3–15; 8:45 am]
Oxycodone (9143) ........................ II
ACTION: Notice of application. BILLING CODE 4410–09–P
Hydromorphone (9150) ................ II
Diphenoxylate (9170) ................... II
DATES: Registered bulk manufacturers of Ecgonine (9180) ........................... II
the affected basic classes, and DEPARTMENT OF JUSTICE Hydrocodone (9193) ..................... II
applicants therefore, may file written Meperidine (9230) ........................ II
comments on or objections to the Drug Enforcement Administration Methadone (9250) ........................ II
issuance of the proposed registration in [Docket No. DEA–392] Morphine (9300) ........................... II
accordance with 21 CFR 1301.33(a) on Thebaine (9333) ........................... II
or before October 5, 2015. Manufacturer of Controlled Oxymorphone (9652) ................... II
Substances Registration: Cody Alfentanil (9737) ........................... II
ADDRESSES: Written comments should Remifentanil (9739) ...................... II
be sent to: Drug Enforcement Laboratories, Inc.
Sufentanil (9740) .......................... II
Administration, Attention: DEA Federal Fentanyl (9801) ............................ II
ACTION: Notice of registration.
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia SUMMARY: Cody Laboratories, Inc. The company plans to manufacture
22152. Request for hearings should be applied to be registered as a the listed controlled substances in bulk
sent to: Drug Enforcement manufacturer of certain basic classes of for sale to its customers.
Administration, Attention: Hearing controlled substances. The Drug Dated: July 29, 2015.
Clerk/LJ, 8701 Morrissette Drive, Enforcement Administration (DEA) Joseph T. Rannazzisi,
Springfield, Virginia 22152. grants Cody Laboratories, Inc. Deputy Assistant Administrator.
SUPPLEMENTARY INFORMATION: The registration as a manufacturer of those
[FR Doc. 2015–19168 Filed 8–3–15; 8:45 am]
Attorney General has delegated his controlled substances.
BILLING CODE P
authority under the Controlled SUPPLEMENTARY INFORMATION: By notice
Substances Act to the Administrator of dated April 14, 2015, and published in
the Drug Enforcement Administration the Federal Register on April 22, 2015, DEPARTMENT OF JUSTICE
(DEA), 28 CFR 0.100(b). Authority to 80 FR 22560, Cody Laboratories, Inc.,
exercise all necessary functions with Steve Hartman-Vice President of Drug Enforcement Administration
respect to the promulgation and Compliance, 601 Yellowstone Avenue,
implementation of 21 CFR part 1301, [Docket No. DEA–392]
Cody, Wyoming 82414 applied to be
incident to the registration of registered as a manufacturer of certain Manufacturer of Controlled
manufacturers, distributors, dispensers, basic classes of controlled substances. Substances Registration: Johnson
tkelley on DSK3SPTVN1PROD with NOTICES

importers, and exporters of controlled No comments or objections were Matthey, Inc.
substances (other than final orders in submitted for this notice.
connection with suspension, denial, or The DEA has considered the factors in ACTION: Notice of registration.
revocation of registration) has been 21 U.S.C. 823(a) and determined that
redelegated to the Deputy Assistant the registration of Cody Laboratories, SUMMARY: Johnson Matthey, Inc. applied
Administrator of the DEA Office of Inc. to manufacture the basic classes of to be registered as a manufacturer of
Diversion Control (‘‘Deputy Assistant controlled substances is consistent with certain basic classes of controlled

VerDate Sep<11>2014 18:45 Aug 03, 2015 Jkt 235001 PO 00000 Frm 00101 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1

Document Created: 2015-12-18 14:51:41
Document Modified: 2015-12-18 14:51:41

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of registration.
FR Citation		80 FR 46334

80 FR 46334 - Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc.

DEPARTMENT OF JUSTICEDrug Enforcement Administration

Federal Register Volume 80, Issue 149 (August 4, 2015)

DEPARTMENT OF JUSTICE
Drug Enforcement Administration